These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...

Good afternoon, and welcome to Jefferson Capital's Fourth Quarter and Full Year 2025 Conference Call. With us today are David Burton, Founder and Chief Executive Officer; and Christo Realov, Chief ...

Officers carried out 30 warrants between 2 and 8 March as part of a national operation targeting organised drug networks. | ITV News Granada ...

Adjusted net loss -- $21 million, a deterioration from the prior quarter's $3 million adjusted net loss, driven mainly by a ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

In Nevada’s Catholic schools, there is only one place where a child with special needs sits beside their classmates, not apart from them. At St. Viator Parish School in central Las Vegas ...

Our results were released this morning in our earnings press release, which can be found on the Investor Relations section of our website along with our supplemental filed with the SEC. A live audio ...

On the high street in Redcar, there’s a shop selling ornamental animals. These range from an £80 model gorilla to a large blue tit – “slightly damaged” and on sale for £2.

As we close 2025 and enter what we expect to be a defining year for Allogene Therapeutics, Inc., the environment around us is shifting. Cell therapy has entered a phase defined by evidence, where ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

Major research hospitals and prestigious universities snared a significant share of Philanthropy 50 gifts, but lesser known ...

CANOPY reports twelve strategies for creating a sustainable, future-proof office by 2026, focusing on effective design, location, and technology.